NPI: 1972767911 · ARTESIA, NM 88210 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/17/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/17/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,689 | $200K |
| 2019 | 2,177 | $159K |
| 2020 | 1,150 | $243K |
| 2021 | 385 | $82K |
| 2022 | 3,247 | $56K |
| 2023 | 4,444 | $134K |
| 2024 | 2,335 | $164K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 12,048 | 1,034 | $983K |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,419 | 100 | $31K |
| A4657 | Syringe, with or without needle, each | 1,056 | 609 | $12K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 1,060 | 52 | $4K |
| J1756 | Injection, iron sucrose, 1 mg | 861 | 193 | $3K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 32 | 14 | $1K |
| 83970 | 180 | 174 | $729.73 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 39 | 37 | $197.69 |
| 83550 | 63 | 60 | $117.06 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 141 | 109 | $107.03 |
| 83540 | 63 | 60 | $86.76 | |
| 85041 | 220 | 209 | $79.63 | |
| 82108 | 12 | 12 | $68.72 | |
| 85048 | 219 | 209 | $67.18 | |
| 82728 | 14 | 13 | $50.27 |